Oncovita

Paris, France

Oncovita is a biotech company focused on developing innovative medications and vaccines, particularly anti-cancer therapies, to save lives.

$4.9M raised

Nov 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Oncovita raised?

Oncovita has raised $4.9M in total funding. The most recent round was Grant. The last funding was announced in November 2023.

Who are Oncovita's investors?

Oncovita's investors include France 2030.

Where is Oncovita headquartered?

Oncovita is headquartered in Paris, France.

What does Oncovita do?

Oncovita is a biotech company focused on developing innovative medications and vaccines, particularly anti-cancer therapies, to save lives.

What stage is Oncovita at?

Oncovita is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 22, 2023.

MLA

"Oncovita — Funding & Investors." VCBacked, November 22, 2023, https://www.vcbacked.co/company/oncovita. Accessed July 4, 2026.

APA

VCBacked. (2023). Oncovita — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/oncovita

Wikipedia (cite web)

{{cite web |title=Oncovita — Funding & Investors |url=https://www.vcbacked.co/company/oncovita |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 22, 2023.